Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BVS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Bioventus Inc

BVS
Current price
6.97 USD -0.35 USD (-4.78%)
Last closed 7.39 USD
ISIN US09075A1088
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 495 072 352 USD
Yield for 12 month +1.01 %
1Y
3Y
5Y
10Y
15Y
BVS
21.11.2021 - 28.11.2021

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise of various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides nexus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company's restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system; and Talisman pulse generator and receiver for peripheral nerve stimulation. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina. Address: 4721 Emperor Boulevard, Durham, NC, United States, 27703

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.33 USD

P/E Ratio

Dividend Yield

Financials BVS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+573 280 000 USD

Last Year

+512 345 000 USD

Current Quarter

+123 876 000 USD

Last Quarter

+153 642 000 USD

Current Year

+388 226 000 USD

Last Year

+328 193 000 USD

Current Quarter

+83 056 000 USD

Last Quarter

+100 888 000 USD
EBITDA 58 809 000 USD
Operating Margin TTM 4.01 %
Price to Earnings
Return On Assets TTM 3.33 %
PEG Ratio 2.14
Return On Equity TTM -20.24 %
Wall Street Target Price 12.33 USD
Revenue TTM 567 699 008 USD
Book Value 2.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -4.30 %
Dividend Yield
Gross Profit TTM 382 902 016 USD
Earnings per share -0.48 USD
Diluted Eps TTM -0.48 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -5.51 %

Stock Valuation BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 11.09
Enterprise Value Revenue 1.46
Price Sales TTM 0.87
Enterprise Value EBITDA 21.52
Price Book MRQ 3.28

Technical Indicators BVS

For 52 Weeks

6.02 USD 14.38 USD
50 Day MA 6.74 USD
Shares Short Prior Month 1 220 931
200 Day MA 9.63 USD
Short Ratio 3.30
Shares Short 1 633 086
Short Percent 4.82 %